enkephalin, leucine has been researched along with Movement Disorders in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanchet, PJ; Lévesque, D; Mahmoudi, S | 1 |
| Blum, D; Ledent, C; Mievis, S | 1 |
| Alberch, J; Bosch, M; Canals, JM; Ernfors, P; Martín-Ibañez, R; Mengod, G; Muñoz, MT; Pineda, JR; Torres-Peraza, JF | 1 |
| Johnston, MV; Singer, HS | 1 |
| Drago, J; Finkelstein, DI; Kola, I; Lakso, M; Lawrence, AJ; McManus, JF; Natoli, AL; Padungchaichot, P; Sumarsono, SH; Westphal, H; Wong, JY; Wreford, N | 1 |
| Bédard, PJ; Di Paolo, T; Goulet, M; Grondin, R; Morissette, M | 1 |
| Campbell, BM; Gresch, PJ; Walker, PD | 1 |
| Cools, AR; Cuypers, E; Spooren, WP | 1 |
1 review(s) available for enkephalin, leucine and Movement Disorders
| Article | Year |
|---|---|
Brain neurotransmitters and neuromodulators in pediatrics.
Topics: Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Brain; Child; Endorphins; Enkephalins; Epilepsy; Humans; Movement Disorders; Neurotransmitter Agents; Pain; Phenylalanine; Psychotic Disorders; Receptors, Neurotransmitter | 1982 |
7 other study(ies) available for enkephalin, leucine and Movement Disorders
| Article | Year |
|---|---|
Upregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model.
Topics: Animals; Antipsychotic Agents; Brain; Cebus; Clozapine; Disease Models, Animal; Dopamine Antagonists; Enkephalins; Female; Haloperidol; Iodine Radioisotopes; Movement Disorders; Neurons; Ovariectomy; Protein Binding; Receptors, Dopamine D2; Receptors, Dopamine D3; Sulpiride; Tetrahydronaphthalenes; Up-Regulation | 2014 |
A2A receptor knockout worsens survival and motor behaviour in a transgenic mouse model of Huntington's disease.
Topics: Animals; Enkephalins; Female; Huntingtin Protein; Huntington Disease; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Movement Disorders; Nerve Tissue Proteins; Neurons; Nuclear Proteins; Receptor, Adenosine A2A; Survival Rate | 2011 |
Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease.
Topics: Age of Onset; Animals; Ataxia; Brain-Derived Neurotrophic Factor; Cell Death; Cell Line, Transformed; Chorea; Corpus Striatum; Crosses, Genetic; Endocytosis; Enkephalins; Gene Expression Regulation; Huntingtin Protein; Huntington Disease; Mice; Mice, Knockout; Mice, Transgenic; Movement Disorders; Nerve Degeneration; Nerve Tissue Proteins; Neurons; Nuclear Proteins; Phenotype; Stem Cells; Transfection; Trinucleotide Repeats | 2004 |
Targeted expression of a toxin gene to D1 dopamine receptor neurons by cre-mediated site-specific recombination.
Topics: Animals; Apoptosis; Basal Ganglia; Diphtheria Toxin; Enkephalins; Gene Expression Regulation, Enzymologic; Glial Fibrillary Acidic Protein; Gliosis; In Situ Hybridization; In Situ Nick-End Labeling; Integrases; Mice; Mice, Transgenic; Microscopy, Electron; Movement Disorders; Myoclonus; Neurons; Parkinson Disease, Secondary; Phenotype; Radioligand Assay; Receptors, Dopamine D1; RNA, Messenger; Substance P; Viral Proteins | 1998 |
Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Benzazepines; Brain Chemistry; Cabergoline; Corpus Striatum; Denervation; Dopamine Agents; Dopamine Agonists; Enkephalins; Ergolines; Female; Gene Expression; Macaca fascicularis; Movement Disorders; Protein Precursors; Pulsatile Flow; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Tachykinins | 1999 |
Neonatal dopamine depletion reveals a synergistic mechanism of mRNA regulation that is mediated by dopamine(D1) and serotonin(2) receptors and is targeted to tachykinin neurons of the dorsomedial striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Animals, Newborn; Dopamine; Dopamine Agonists; Dopamine Antagonists; Drug Synergism; Enkephalins; Gene Expression Regulation, Developmental; Male; Movement Disorders; Neostriatum; Neurons; Oxidopamine; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Serotonin; RNA, Messenger; Serotonin Antagonists; Serotonin Receptor Agonists; Tachykinins | 2001 |
Oro-facial dyskinesia and the sub-commissural part of the globus pallidus in the cat: role of acetylcholine and its interaction with GABA.
Topics: Acetylcholine; Animals; Behavior, Animal; Carbachol; Cats; Enkephalins; gamma-Aminobutyric Acid; Globus Pallidus; Male; Movement Disorders | 1989 |